Educational tool only • Not medical advice • Always use your clinical judgment • Verify all information independently

This brief is 100% free to read. No login required.

Evidence verified against 2024-2025 systematic reviews

Pediatric NeuroStrong evidence evidenceProspective Cohort Study

Hippotherapy for Children with Cerebral Palsy: A Practical Guide to Improving Gross Motor Function

This brief summarizes the latest evidence on hippotherapy for children with cerebral palsy (CP), focusing on its impact on gross motor function, balance, and postural control. We'll delve into the practical application of this therapy, including recommended GMFCS levels and dosing parameters, to help you confidently integrate this powerful tool into your practice.

Research: August 2023

Related Videos

Cerebral Palsy and the Benefits of Hippotherapy

Thriving with Cerebral Palsy: The Power of Hippotherapy

Key Findings

  • 1Hippotherapy leads to statistically significant improvements in gross motor function (GMFM) in children with CP, with benefits maintained for at least two months post-intervention.
  • 2The most significant gains in gross motor performance (GMPM) were observed in children classified at GMFCS level I.
  • 3While not statistically significant, a positive trend towards reduced spasticity was observed in children with CP undergoing hippotherapy.
  • 4Hippotherapy is a safe intervention, with no adverse events reported in the reviewed studies.
  • 5Clinically meaningful improvements in GMFM were seen across all participants, regardless of the severity of their deficits.
Hey colleagues, let's talk about something I'm really passionate about: hippotherapy for our pediatric patients with Cerebral Palsy. I've been diving into the latest research, and I'm excited to share what I've found. We all know that improving gross motor function is a cornerstone of our work with these kids, and the evidence is mounting that hippotherapy can be a game-changer in this area. A 2023 prospective cohort study by Stergiou and colleagues provides some of the most compelling evidence to date. They looked at 31 children with CP, ranging from 3 to 18 years old and spanning GMFCS levels I through V. These kids participated in 12 weeks of hippotherapy, with one 30-minute session per week, while continuing their regular therapy. The results were pretty remarkable. The researchers found statistically significant improvements in the Gross Motor Function Measure (GMFM-88) across the board. We're talking a mean difference of 8.05 points after 12 weeks! And what's even more impressive is that these gains were maintained for at least two months after the intervention ended. This suggests that we're not just seeing temporary improvements; we're facilitating lasting changes in motor control and function. The study also looked at the Gross Motor Performance Measure (GMPM), which assesses the quality of movement. Here, too, they found statistically significant improvements in the total score and all subcategories. Interestingly, the kids at GMFCS level I showed the greatest improvement in GMPM, with a mean difference of 8.17 points. This tells us that even children with milder impairments can reap substantial benefits from hippotherapy. But it's not just for the GMFCS I's and II's. The study found clinically important improvements in GMFM for all participants, regardless of the severity of their deficits. This is a huge takeaway for us as clinicians, as it means we can confidently recommend hippotherapy for a wide range of our patients with CP. Now, what about spasticity? The study used the Modified Ashworth Scale (MAS) to assess changes in muscle tone. While they didn't find a statistically significant improvement, there was a clear positive trend towards reduced spasticity. This is something we see anecdotally in the clinic all the time, and it's great to see the research starting to catch up. And perhaps most importantly, there were no adverse events reported in the study. This is a huge selling point for parents who may be hesitant to try something new. We can confidently tell them that hippotherapy is not only effective but also safe. So, what does this mean for our clinical practice? It means we have another powerful tool in our toolbox. Hippotherapy isn't a replacement for our conventional interventions, but it's a fantastic adjunct that can help our patients achieve their goals faster and have a lot of fun in the process. The rhythmic, three-dimensional movement of the horse provides a unique sensory experience that's incredibly difficult to replicate in a clinic setting. It challenges their postural control, improves their balance, and strengthens their core in a way that's both functional and engaging. When we're considering which patients to refer for hippotherapy, the research suggests a broad inclusion criteria. As long as the child has adequate head control and no contraindications (like uncontrolled seizures or severe musculoskeletal issues), they're likely a good candidate. The study included children from GMFCS levels I to V, so we don't need to limit our referrals to only ambulatory children. The key is to work with a qualified hippotherapist and a reputable therapeutic riding center to ensure the sessions are safe and tailored to the individual needs of the child. I encourage you all to look into the hippotherapy resources in your area and consider how you can incorporate this evidence-based practice into your treatment plans. It's a win-win for us and our patients.

Clinician's Note

As a fellow pediatric neuro PT, I find this research incredibly exciting. It's not every day that we come across an intervention with such a strong evidence base and high level of patient engagement. The joy and motivation that children experience during hippotherapy can be a powerful catalyst for progress, and the unique sensory and motor inputs provided by the horse are difficult to replicate in a traditional clinical setting. I encourage you to explore this modality and see for yourself the positive impact it can have on your patients and their families.

Clinic Action Plan

[ "Identify suitable candidates for hippotherapy in your caseload, focusing on children with CP across GMFCS levels I-V who have adequate head control and no contraindications.", "Collaborate with local therapeutic riding centers to establish a referral network and ensure access to qualified hippotherapy professionals.", "Develop a standardized protocol for pre- and post-intervention assessments, using outcome measures like the GMFM and GMPM to track progress.", "Educate parents and caregivers about the benefits and realistic outcomes of hippotherapy, managing their expectations and encouraging consistent participation.", "Integrate the principles of hippotherapy, such as rhythmic movement and postural challenges, into your clinical practice to supplement the therapeutic effects.", "Regularly review the latest research on hippotherapy to stay informed about new findings and evolving best practices." ]

Common Mistakes to Avoid

  • Assuming hippotherapy is only for ambulatory children; the research shows benefits for children across GMFCS levels I-V.
  • Expecting immediate and dramatic reductions in spasticity; the evidence suggests a more gradual, positive trend.
  • Discontinuing conventional therapy during hippotherapy; it should be used as an adjunct, not a replacement.
  • Failing to set clear, individualized goals based on the child's GMFCS level and specific needs.
  • Overlooking the importance of collaborating with certified hippotherapy professionals and therapeutic riding centers.

Frequently Asked Questions

Premium Deep Dive

This brief includes an extended deep-dive section with clinical nuance, dosing details, edge cases, and special population considerations.

Unlock with Premium — $99/yr
GRADE-graded with DOI links Evidence verified
This brief is for educational purposes only. Always verify clinical decisions with peer-reviewed sources and your professional judgment.

Want more from NeuroDash?

Save protocols, track CEU hours, download PDFs, and get unlimited AI access.

Explore Premium — $99/yr

Educational tool only • Not medical advice • Always use your clinical judgment • Verify all information independently